Allergan has announced that Wayne Swanton has been promoted to Executive Vice President, Global Operations following notification that Rob Stewart, Executive Vice President and Chief Operating Officer, intends to leave Allergan to become President and CEO of Amneal Pharmaceuticals in 2018.
Wayne Swanton will join Allergan’s Executive Leadership Team and maintain responsibility for Global Manufacturing, Quality, Supply Chain, Procurement, Pharmaceutical Technology, Operational Excellence, Engineering, Environmental Health & Safety and Security.
“Wayne Swanton has led our global operations team during a period of rapid change, including the acquisition of Forest Labs and Allergan, as well as the divestiture of our global generics business. Through all of those changes, Wayne’s team has maintained high-quality standards, dramatically increased efficiency of our manufacturing operations and supply chain through operational excellence, improved on-time delivery of products to customers, provided increased value across Allergan through our procurement team while driving an industry leading environmental health & safety culture,” said Brent Saunders, Chairman and Chief Executive Officer.
“Rob Stewart has been a key part of the transformation of our company from a generic manufacturer to a leading branded pharmaceutical innovator over the past eight years. During his time, he helped streamline manufacturing, enhance operational excellence, and played an instrumental role in integrating many companies into Allergan. Our focus on succession planning and Rob’s leadership in developing a strong bench has enabled us to have a smooth transition of his responsibilities. I thank Rob for his contributions and wish him success on his next career opportunity,” added Saunders.